The money will be doled out to the team over the next five years. It will allow the researchers to continue their work, which is aimed at achieving an understanding of the molecular pharmacology of currently used general anesthetics, and then utilizing this understanding to improve current drugs and discover new compounds for better patient care.
More Articles on Anesthesia:
MEDNAX Acquires Northern Westchester Anesthesia Services
ASA Criticizes Proposed VA Nursing Handbook
2 Tools Anesthesiologists Can Use to Evaluate Third Party Payer Performance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.